Clearlake Capital closed Fund VIII at $14.8 billion, the largest U.S. private-equity fund raised in the past eighteen months and a 40% increase over its 2021 predecessor. The Santa Monica firm notified LPs of the final close last week, confirming investor commitments that began circulating in institutional circles in November. No other technology-focused buyout fund has crossed $10 billion since Thoma Bravo's fourteenth vehicle at $12.4 billion in early 2023.
The raise comes after Clearlake acquired three separate platforms to deepen its alternatives footprint: insurance specialist Inscope in June 2023, a secondaries business from Lexington Partners in September, and a credit unit from Magnetar in February of this year. Those bolt-ons added $8.2 billion in assets under management and gave the firm exposure to three liquidity windows that do not depend on exit markets. Co-founders Behdad Eghbali and José Feliciano now oversee $85 billion across buyout, credit, secondaries, and structured insurance mandates, a 180% expansion since 2020.
The timing matters because most firms that marketed flagship funds in 2023 and 2024 came in 20% to 40% below target. Silver Lake cut its ninth vehicle from a $20 billion goal to $15 billion. Vista Equity Partners stretched its eighth fund over fourteen months and still closed at $16.3 billion against a $20 billion ask. Clearlake's oversubscription signals that allocators are paying for two things: demonstrable exits in a frozen market and adjacent revenue streams that hedge against hold-period drift. The firm returned $4.1 billion to investors in 2023 alone, mostly through dividend recaps and continuation vehicles rather than outright sales. That cash discipline kept re-up rates north of 90% even as public pensions reduced PE allocations by an average of 160 basis points.
The fund's sector tilt is software and tech-enabled services, the same mandate as Fund VII, but internal positioning has shifted. Clearlake is now running a parallel credit strategy that co-invests alongside equity checks, providing mezzanine financing at spreads near L+650 when syndicated markets price similar paper at L+500. That gap reflects control premium and structural seniority, but it also creates a built-in margin for the firm when sponsors hold assets beyond year five. Portfolio companies held longer than 60 months now represent 38% of Fund VII by capital deployed, up from 14% in Fund VI at the same vintage point. The credit arm converts extended hold periods from a drag into a yield generator.
Allocators should track three follow-on events. First, whether Clearlake attempts to raise a dedicated continuation fund in mid-2025 to warehouse Fund VII assets that cannot exit cleanly; institutional chatter suggests a $3 billion to $4 billion vehicle is in early design. Second, whether the firm's insurance subsidiary begins writing collateral protection for portfolio-company debt, effectively self-insuring credit exposure and compressing all-in financing costs by 70 to 90 basis points. Third, watch for a potential bid on a larger secondaries platform; the Lexington unit handles $900 million in annual volume, but firms managing $4 billion-plus in secondary capital are beginning to explore sales as founder teams age out.
Thoma Bravo is already in the market for Fund XV, targeting $16 billion with a March first close.